ACM
SPRB
Aisling Capital Management’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,205,511
| Closed | -$948K | – | 16 |
|
|
2024
Q1 | $948K | Hold |
1,205,511
| – | – | 0.32% | 14 |
|
|
2023
Q4 | $3.53M | Hold |
1,205,511
| – | – | 1.05% | 8 |
|
|
2023
Q3 | $2.72M | Hold |
1,205,511
| – | – | 1.12% | 10 |
|
|
2023
Q2 | $2.59M | Hold |
1,205,511
| – | – | 1.27% | 10 |
|
|
2023
Q1 | $2.66M | Hold |
1,205,511
| – | – | 1.28% | 11 |
|
|
2022
Q4 | $1.32M | Hold |
1,205,511
| – | – | 0.87% | 11 |
|
|
2022
Q3 | $1.65M | Hold |
1,205,511
| – | – | 1.1% | 11 |
|
|
2022
Q2 | $2.1M | Hold |
1,205,511
| – | – | 1.5% | 12 |
|
|
2022
Q1 | $2.42M | Hold |
1,205,511
| – | – | 1.31% | 14 |
|
|
2021
Q4 | $5.38M | Hold |
1,205,511
| – | – | 1.9% | 14 |
|
|
2021
Q3 | $7.25M | Hold |
1,205,511
| – | – | 1.44% | 13 |
|
|
2021
Q2 | $13.5M | Hold |
1,205,511
| – | – | 2.16% | 7 |
|
|
2021
Q1 | $20M | Hold |
1,205,511
| – | – | 3.6% | 5 |
|
|
2020
Q4 | $29.3M | Buy |
+1,205,511
| New | +$29.3M | 5.03% | 4 |
|